tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Nephritis, Hereditary D009394 1 associated lipids
Mastocytosis, Cutaneous D034701 1 associated lipids
Pancreatitis, Graft D055589 1 associated lipids
Hearing Loss, Sudden D003639 1 associated lipids
Rectal Diseases D012002 1 associated lipids
Citrullinemia D020159 1 associated lipids
Pulmonary Veno-Occlusive Disease D011668 1 associated lipids
Sweet Syndrome D016463 1 associated lipids
Optic Neuritis D009902 1 associated lipids
Granuloma Annulare D016460 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Nakagawa K et al. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. 2015 Am. J. Reprod. Immunol. pmid:25394810
Farnik H et al. Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation. 2015 Liver Int. pmid:24649882
Prinz V et al. MRI heralds secondary nigral lesion after brain ischemia in mice: a secondary time window for neuroprotection. 2015 J. Cereb. Blood Flow Metab. pmid:26126863
Cantaluppi V et al. Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors. 2015 PLoS ONE pmid:26125566
Fukahori H et al. Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation. 2015 Int. Immunopharmacol. pmid:26122135
Langone A et al. Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study. 2015 Clin Transplant pmid:26113208
Eidens M et al. Development and validation of a rapid and reliable real-time PCR method for CYP3A5 genotyping. 2015 Clin. Lab. pmid:25975003
Castaneda J and Matzuk MM DEVELOPMENTAL BIOLOGY. Toward a rapid and reversible male pill. 2015 Science pmid:26494747
Carenco C et al. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors. 2015 Liver Int. pmid:25488375
Safa K et al. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report. 2015 Clin. Nephrol. pmid:24495904
Wozniak LJ et al. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. 2015 Transplantation pmid:26038872
Staatz CE and Tett SE Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients. 2015 Clin Pharmacokinet pmid:26038096
Migita K et al. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus. 2015 Arthritis Res. Ther. pmid:26036592
Garcia C et al. Collaborative Brazilian Pediatric Renal Transplant Registry (CoBrazPed-RTx): A Report From 2004 to 2013. 2015 Transplant. Proc. pmid:26036492
Miyata H et al. Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive. 2015 Science pmid:26429887
Jin S et al. Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin. 2015 Gastroenterology pmid:25980752
Wiseman AC Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know. 2015 Clin J Am Soc Nephrol pmid:25979977
Ratanatharathorn V et al. Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT. 2015 Bone Marrow Transplant. pmid:25285804
Tanriover B et al. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. 2015 Clin J Am Soc Nephrol pmid:25979971
Meyer C et al. Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques. 2015 Clin. Exp. Immunol. pmid:25902927
Sassi MB et al. Involvement of CYP 3A5 In the Interaction Between Tacrolimus and Nicardipine: A Case Report. 2015 Curr Drug Saf pmid:25968921
Wang CY et al. Analysis of tacrolimus blood concentrations in renal transplant patients. 2015 Genet. Mol. Res. pmid:25966149
Wang L et al. Benefits of minimizing immunosuppressive dosage according to cytochrome P450 3A5 genotype in liver transplant patients: findings from a single-center study. 2015 Genet. Mol. Res. pmid:25966085
Bedi M and Taylor AL Recalcitrant Hailey-Hailey disease responds to oral tacrolimus and botulinum toxin type A. 2015 Cutis pmid:26761940
Antonini TM et al. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. 2015 AIDS pmid:25387314
Blasco-Morente G et al. Long-Standing Presternal Plaque. 2015 Actas Dermosifiliogr pmid:25917959
Ferraresso M et al. Relationship between mRNA expression levels of CYP3A4, CYP3A5 and SXR in peripheral mononuclear blood cells and aging in young kidney transplant recipients under tacrolimus treatment. 2015 Pharmacogenomics pmid:25916520
Nagaya M et al. A new system to evaluate the influence of immunosuppressive drugs on pancreatic islets using epigenetic analysis in a 3-dimensional culture. 2015 Pancreas pmid:25906448
Wang M et al. Enteric polymer based on pH-responsive aliphatic polycarbonate functionalized with vitamin E to facilitate oral delivery of tacrolimus. 2015 Biomacromolecules pmid:25714622
Gallon L et al. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. 2015 Transplantation pmid:25905982
Berro M et al. Allogeneic hematopoietic stem cell transplantation in the elderly. Predicting the risk for non relapse mortality. 2015 Medicina (B Aires) pmid:26339873
Gajzlerska W et al. Use of three-carbon chain compounds as biosynthesis precursors to enhance tacrolimus production in Streptomyces tsukubaensis. 2015 N Biotechnol pmid:25152525
Robertsen I et al. Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed. 2015 Transplantation pmid:25148382
Yu Z et al. IL-15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice. 2015 Mol Med Rep pmid:25333459
Selk A A Survey of Experts Regarding the Treatment of Adult Vulvar Lichen Sclerosus. 2015 J Low Genit Tract Dis pmid:25853633
Hurst AL et al. Supra-therapeutic tacrolimus concentrations associated with concomitant nicardipine in pediatric liver transplant recipients. 2015 Pediatr Transplant pmid:25850753
Tajdaran K et al. A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506). 2015 Biotechnol. Bioeng. pmid:25850693
Wang L et al. Effect of CYP3A5 gene polymorphisms on tacrolimus concentration/dosage ratio in adult liver transplant patients. 2015 Genet. Mol. Res. pmid:26634478
Jacobo-Cabral CO et al. Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation. 2015 Br J Clin Pharmacol pmid:25846845
Wang L et al. Gq signaling causes glomerular injury by activating TRPC6. 2015 J. Clin. Invest. pmid:25844902
Bowman LJ et al. Tacrolimus-Induced Cardiomyopathy in an Adult Renal Transplant Recipient. 2015 Pharmacotherapy pmid:26616582
Miguel-Gómez L et al. [Peristomal pyoderma gangrenosum associated with colon cancer]. 2015 Med Clin (Barc) pmid:25659860
Romanowski M et al. Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus. 2015 Pharmacogenomics pmid:26282401
Girdlestone J et al. Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs. 2015 Cytotherapy pmid:26276002
Solomon SR et al. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. 2015 Biol. Blood Marrow Transplant. pmid:25797174
Dedinská I et al. Waist circumference as an independent risk factor for NODAT. 2015 Ann. Transplant. pmid:25791039
Suzuki N et al. In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain. 2015 PLoS ONE pmid:25790231
Ross A and Kirsner RS JID VisualDx Quiz: April 2015. 2015 J. Invest. Dermatol. pmid:25785952
Heneberg P et al. Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro. 2015 PLoS ONE pmid:26562153
Plischke M et al. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. 2015 PLoS ONE pmid:26270340
Yang CJ et al. Differential Large-Amplitude Breathing Motions in the Interface of FKBP12-Drug Complexes. 2015 Biochemistry pmid:26561008
Dias PH et al. Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion. 2015 Acta Cir Bras pmid:25714692
Fan J et al. Donor IL-18 rs5744247 polymorphism as a new biomarker of tacrolimus elimination in Chinese liver transplant patients during the early post-transplantation period: results from two cohort studies. 2015 Pharmacogenomics pmid:25712187
Morales E et al. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab. 2015 Transpl. Int. pmid:25712140
San Miguel C et al. Immunosuppression Strategies in the Treatment of Hepatocellular Carcinoma in Virgen de las Nieves University Hospital. 2015 Transplant. Proc. pmid:26518930
Jia N et al. Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature. 2015 BMC Cancer pmid:26197890
Duong SQ et al. Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients. 2015 Pediatr Transplant pmid:26497983
Jóźwiak-Bębenista M et al. The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation. 2015 Pharmacol Rep pmid:25712659
Kadlub N et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. 2015 J. Bone Miner. Res. pmid:25491283
Pucci N et al. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study. 2015 Pediatr Allergy Immunol pmid:25712437
Katayama K et al. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice. 2015 Mod Rheumatol pmid:24983407
Kim KW et al. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. 2015 Immunology pmid:24974886
Yessayan L et al. Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation. 2015 Transplant. Proc. pmid:26707323
Dumortier T et al. Estimating the contribution of everolimus to immunosuppressive efficacy when combined with tacrolimus in liver transplantation: a model-based approach. 2015 Clin. Pharmacol. Ther. pmid:25669933
Yoon NY et al. Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. 2015 Arch. Dermatol. Res. pmid:25786383
Tanaka M et al. Corticosteroid and tacrolimus treatment in neuromyelitis optica related disorders. 2015 Mult. Scler. pmid:25662352
Van der Perren A et al. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease. 2015 Neurobiol. Aging pmid:25660193
Ayala E et al. Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma. 2015 Clin Lymphoma Myeloma Leuk pmid:25659459
Wu SC et al. Identification of Circulating miRNAs in a Mouse Model of Nerve Allograft Transplantation under FK506 Immunosuppression by Illumina Small RNA Deep Sequencing. 2015 Dis. Markers pmid:26435568
Polańska A et al. Monitoring of therapy in atopic dermatitis--observations with the use of high-frequency ultrasonography. 2015 Skin Res Technol pmid:24894324
Okechuku G et al. Anorexia nervosa in a pediatric renal transplant recipient and its reversal with cyclosporine. 2015 Pediatr Transplant pmid:25661468
Xie X et al. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis. 2015 BMC Nephrol pmid:26126806
Kume K et al. Screening for a gene deletion mutant whose temperature sensitivity is suppressed by FK506 in budding yeast and its application for a positive screening for drugs inhibiting calcineurin. 2015 Biosci. Biotechnol. Biochem. pmid:25614218
Garnock-Jones KP Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients. 2015 Drugs pmid:25613762
Li CJ and Li L Tacrolimus in preventing transplant rejection in Chinese patients--optimizing use. 2015 Drug Des Devel Ther pmid:25609922
Oguni H and Hayashi M [Topics for authorization of new intravenous antiepileptic drugs and tacrolimus for autoimmune epilepsy]. 2015 No To Hattatsu pmid:26349372
Uemoto S et al. Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8+ central memory and effector T cells for better clinical outcomes in liver transplant recipients. 2015 Clin. Exp. Immunol. pmid:25603847
Dave CN et al. Innovative use of intravesical tacrolimus for hemorrhagic radiation cystitis. 2015 Int Urol Nephrol pmid:26347076
Oda K et al. In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure. 2015 Biopharm Drug Dispos pmid:25600613
Wu J et al. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes. 2015 J. Clin. Invest. pmid:26436650
Overk CR et al. Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506. 2015 Neuroscience pmid:26341908
de Jonge H et al. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit. 2015 Br J Clin Pharmacol pmid:26114223
Kallscheuer N et al. Single-Domain Peptidyl-Prolyl cis/trans Isomerase FkpA from Corynebacterium glutamicum Improves the Biomass Yield at Increased Growth Temperatures. 2015 Appl. Environ. Microbiol. pmid:26341203
Sánchez-Lázaro I et al. Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation. 2015 Pharmacogenomics pmid:26107754
Bhadauria D et al. Cryptosporidium infection after renal transplantation in an endemic area. 2015 Transpl Infect Dis pmid:25620388
Schnitzbauer AA et al. Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation. 2015 Ann. Transplant. pmid:25553853
Burke MT et al. Genetics and nonmelanoma skin cancer in kidney transplant recipients. 2015 Pharmacogenomics pmid:25616102
Schnitzler F et al. Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort. 2015 PLoS ONE pmid:26288187
Urquhart BL and Knauer MJ Dried blood spots for therapeutic drug monitoring of tacrolimus and sirolimus in pediatric patients. 2015 Pediatr Transplant pmid:25546506
Aruch DB and Renteria A Simultaneous PRES and TMA secondary to tacrolimus after allogeneic bone marrow transplant. 2015 Blood pmid:26287041
Pagliarello C et al. Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison. 2015 Eur J Dermatol pmid:25786341
Hauch A et al. Generics: are all immunosuppression agents created equally? 2015 Surgery pmid:26206317
Gong N et al. Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients. 2015 Cell. Immunol. pmid:26205091
Chamani G et al. Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis. 2015 Int. J. Dermatol. pmid:26204904
Muduma G et al. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK. 2015 J Med Econ pmid:26201252
Mizuno K et al. Dexamethasone but not tacrolimus suppresses TNF-α-induced thymic stromal lymphopoietin expression in lesional keratinocytes of atopic dermatitis model. 2015 J. Dermatol. Sci. pmid:26198442
Rathi M et al. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. 2015 Transplant. Proc. pmid:26036543
Mohsin N et al. Pharmacokinetics of mycophenolate mofetil in Omani patients on cyclosporine or tacrolimus. 2015 Transplant. Proc. pmid:26036534
Türkoğlu O et al. Are antimicrobial peptides related to cyclosporine A-induced gingival overgrowth? 2015 Arch. Oral Biol. pmid:25555253
Rivinius R et al. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy. 2015 Drug Des Devel Ther pmid:25552900